Symposium “New Frontier in Chemical Biology”
25. July 2024
Joint symposium CNATM, SFB1309 and Center of Advanced Study (CAS) taking place at LMU Großhadern.
We are welcoming our guests Prof. Ashraf Brik (Technion Haifa, IL), Prof. Tom Brown (Oxford, UK), Prof. Yael David (Memorial Sloan Kettering Cancer Center, New York, US), Prof. Katharina Höfer (MPI Marburg, DE) and Prof. Benjamin List (MPI Mülheim, DE, Nobel Laureate 2021).
Please register by sending an email to: info@cas.lmu.de
![](https://cnatm.de/wp-content/uploads/2024/06/20240725_symposium.png)
![News_Beitragsbild](https://cnatm.de/wp-content/uploads/2024/08/News_Beitragsbild.png)
Reinhart-Koselleck-Grant for Prof. Irmela Jeremias
Reinhart-Koselleck-Grant for Prof. Irmela Jeremias
Prof. Irmela Jeremias is a pediatrician at the...
![ERC](https://cnatm.de/wp-content/uploads/2024/07/ERC-1.png)
Proof of Concept Grant for Thomas Carell
The European Research Council has awarded the LMU chemist a grant for the preclinical development of...
![RNhale-logo5](https://cnatm.de/wp-content/uploads/2024/05/RNhale-logo5.png)
LMU Spin-off RNhale gegründet
The formation of the biotech spinoff RNhale can be traced back to Professor Olivia Merkel's groundbreaking...
![tandem-click2](https://cnatm.de/wp-content/uploads/2024/05/tandem-click2.png)
Click-Synthese von Zucker-modifizierten Oligonukleotiden
Nucleic acids in the form of siRNA, antisense oligonucleotides or mRNA are currently explored as new...
![EpiCure_resize](https://cnatm.de/wp-content/uploads/2024/05/EpiCure_resize.png)
EpiCure gewinnt 2. Runde beim Businessplanwettbewerb
EpiCure, eine Firmenidee, die auf Ausgründung wartet, gehört mir ihrem Konzept zu den 5 Siegern...
![Eisbach2](https://cnatm.de/wp-content/uploads/2024/05/Eisbach2.png)
EisbachBio GmbH: Allosterischen Inhibitor erhält FDA-Freigabe
Eisbach Bio GmbH (“Eisbach” or the “Company”), a privately-held clinical-stage biotechnology company...
![QuGen2](https://cnatm.de/wp-content/uploads/2024/05/QuGen2.png)
LMU Spin-off: Gründung der QuGen GmbH
Die QuGen GmbH, gegründet von Thomas Carell und Pascal Giehr, bietet hoch-sensitive Long-read Sequenzierung...